ZYZenghui Yue

Zenghui Yue

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Zenghui Yue has a total of 113 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Protocol for a Randomized Controlled Trial of a Clinician-Supervised Home–School–Hospital-Linked Digital-Health-Platform-Supported Conservative Management Pathway for Adolescent Idiopathic Scoliosis

    by Qinghong Zeng, Zenghui Yue, Li Zhang, Xinyun Li, Rong Hu

    Background/Objectives: Adolescent idiopathic scoliosis (AIS) brings substantial physical and psychological burden for affected teenagers. Current conservative follow-up management is fragmented under routine clinical settings. This study aims to assess the effectiveness of a multimodal health-management-platform-assisted care pathway for adolescents with idiopathic scoliosis receiving conservative treatment. Methods: This is a single-center, superiority, parallel-group, 1:1 randomized controlled trial with assessor-blinded outcome evaluation. A total of 76 eligible adolescent participants will be randomly allocated into either the control group receiving routine guideline-based conservative care or the intervention group receiving clinician-supervised platform-supported collaborative care. Participants will complete assessments at baseline and at 4 months (primary endpoint), 8 months, and 12 months of follow-up. The primary outcome is the change in Cobb angle from baseline to 4 months. Secondary outcomes include treatment adherence, mental health status, medical expenditure, participant and guardian satisfaction, and safety outcomes. The primary analysis will follow the intention-to-treat principle. This manuscript describes the trial protocol. The first participant was enrolled on 26 March 2025; to date, 35 out of the target 76 participants have been recruited. No primary endpoint outcome data have been unlocked or analyzed at the time of this protocol version. Conclusions: This trial will evaluate whether a clinician-supervised, platform-supported collaborative care pathway improves Cobb-angle outcomes and care-process measures compared with routine guideline-based conservative care in adolescents with idiopathic scoliosis. This trial will generate comparative evidence regarding clinical effectiveness and the care-process value of platform-supported collaborative care for conservatively managed AIS adolescents.

  • Open Access

    The role of astrocytes in ischemic stroke

    by ZiYan Lin, You Zhang, MinZhi Li, BaiZhi Lin, Huan Liang, LiZhen Yi, Si Yuan, Zenghui Yue

    Background: Astrocytes, the most abundant glial cells in the central nervous system, play essential roles in maintaining neuronal homeostasis, regulating neurovascular function, and modulating inflammatory responses after ischemic stroke. Although increasing evidence indicates that astrocytes contribute to both neuroprotection and injury progression, the global research landscape and emerging trends in astrocyte-related ischemic stroke research remain unclear. This study aimed to systematically characterize the development, hotspots, and future directions of this field using bibliometric analysis. Methods: Publications related to astrocytes and ischemic stroke were retrieved from the Web of Science Core Collection database between January 1, 2015 and July 1, 2026. A total of 2690 publications were included for analysis. VOSviewer, CiteSpace, and the R package bibliometrix were used to evaluate publication trends, international and institutional collaborations, journal and author contributions, co-citation networks, keyword co-occurrence, and emerging research themes. Results: The annual publication output showed a continuous increasing trend, indicating growing interest in astrocyte-related ischemic stroke research. A total of 72 countries/regions contributed to this field, with China (1372 publications, 34.73%) and the United States (461 publications, 20.49%) being the leading contributors. Shanghai Jiao Tong University was the most productive institution (149 publications). The most active journals included International Journal of Molecular Sciences, Molecular Neurobiology, and Journal of Neuroinflammation, while Stroke, Journal of Cerebral Blood Flow & Metabolism, and Journal of Neuroscience showed strong co-citation influence. Citation and keyword analyses revealed that major research themes focused on astrocyte activation, oxidative stress, neuroprotection, blood-brain barrier regulation, neurovascular interactions, microglia-associated inflammation, energy metabolism, NLRP3 inflammasome, pyroptosis, epigenetic regulation, and endoplasmic reticulum stress. Conclusion: This bibliometric analysis provides a comprehensive overview of global research trends in astrocyte-related ischemic stroke. The field has evolved from investigating general astrocytic responses toward exploring molecular mechanisms, cellular interactions, and targeted regulatory strategies. Future studies should further elucidate astrocyte heterogeneity, metabolic and inflammatory regulation, and neurovascular unit interactions to facilitate the development of astrocyte-targeted therapeutic approaches.

  • Open Access

    Disrupted Enteric Glial Cell Circadian Oscillation: A Proposed Mechanism Linking CMM-Axis Desynchronization, Gut Jet Lag, and Chronic Functional Constipation

    by Yihan Xiong, Lanlan Wang, Yanxi Guo, Yating Lou, Zenghui Yue, Rong Hu

    Chronic functional constipation is highly prevalent and frequently recurrent, and gut jet lag triggered by circadian-rhythm disruption represents an important modern-lifestyle-associated risk factor. Although the Chrono-Microbiota–Motility (CMM)-axis conceptual framework for circadian-disruption-related functional constipation has been published, existing work mainly describes macroscopic microbiota–motility crosstalk and largely overlooks enteric glial cells (EGCs) as secondary peripheral circadian relays within the gut wall. Drawing on evidence from population-based epidemiology, human colonic specimens, multi-omics studies, and animal models of circadian disruption, this review delineates the pathological mechanisms by which disrupted circadian oscillations of enteric glial cells mediate hierarchical desynchronization of the CMM axis and contribute to gut jet lag. It further outlines a progressive pathological cascade from external circadian perturbations and enteric glial cell clock disruption to host–microbiota temporal desynchronization and subsequent collapse of the colonic motility network, discusses the potential implications of this mechanism for clinical risk stratification in chronic functional constipation, and provides a theoretical basis for future basic and translational research in gut chronobiology. It should be emphasised that the integrated mechanistic framework presented herein constitutes a testable hypothesis largely built upon pre-clinical animal observations and indirect human tissue evidence, rather than an established pathophysiological reality. This framework highlights one potential interstitial branch within the complex multi-cellular gut circadian regulatory network.

  • Open Access

    Clinical severity predominates over routine inflammatory and metabolic biomarkers in predicting hemorrhagic transformation after intravenous thrombolysis: internal temporal validation of incremental biomarker value

    by Huan Liang, Baiyu Zeng, Jingquan Wang, Lizhen Yi, Linxing Huang, Ziyan Lin, Cai Zhou, Zenghui Yue

    Background and Objective: Hemorrhagic transformation (HT) remains an important safety concern after intravenous thrombolysis for acute ischemic stroke. We evaluated whether routine inflammatory and metabolic biomarkers improve HT prediction beyond clinical features. Methods: We analyzed 847 thrombolysis-treated admissions from 2020 to 2026. In-hospital imaging-confirmed HT was the primary outcome, and strict 7-day ECASS II-compatible symptomatic intracranial hemorrhage (sICH) was exploratory. Admission date defined derivation ( n = 593; 67 HT events) and internal temporal-validation ( n = 254; 27 HT events) cohorts. The six-variable clinical model included age, baseline NIHSS, atrial fibrillation, large-vessel occlusion, the rapid-glucose field, and onset-to-treatment time. Models added ln(NLR), AIP plus residual cholesterol, or all three biomarkers. Twenty imputed datasets were generated using derivation-fitted imputation models. We assessed discrimination, calibration, Brier score, decision curves, and sensitivity analyses. Results: HT occurred during 94 of 847 admissions (11.1%). The clinical model yielded AUCs of 0.812 (95% CI 0.761–0.860) in derivation and 0.801 (0.707–0.881) in temporal validation. Adding ln(NLR) increased the validation AUC to 0.818 (ΔAUC +0.017; DeLong p = 0.220). Adding AIP and residual cholesterol yielded an AUC of 0.803 (ΔAUC +0.002; p = 0.818). The full model yielded AUCs of 0.817 in derivation and 0.818 in validation (ΔAUC +0.018; p = 0.346). Baseline NIHSS was independently associated with HT (OR 1.084 per point, 95% CI 1.044–1.126; p < 0.001). Atrial fibrillation was independently associated with HT (OR 2.66, 95% CI 1.34–5.27; p = 0.005). The biomarkers ln(NLR), AIP, and residual cholesterol were not independently associated with HT. Validation calibration was similar, with a Brier score of 0.081 for both models. Biomarker gains were inconsistent across sensitivity analyses. In the exploratory sICH analysis (37 events), ln(NLR) was associated with sICH (OR 1.89, 1.04–3.42; p = 0.037). Validation included only 12 events, and the AUC increment was not statistically significant ( p = 0.097). Conclusion: Clinical severity and established clinical features provided most of the predictive information for post-thrombolysis HT. Routine ln(NLR), AIP, and residual cholesterol did not provide sufficiently robust incremental predictive value beyond the clinical model. The NLR–sICH signal remains exploratory and requires external validation.

  • Open Access

    A cumulative biochemical profile of low uric acid and high total bilirubin is associated with hemorrhagic transformation after intravenous thrombolysis in acute ischemic stroke: a retrospective cohort study

    by Huan Liang, Baiyu Zeng, Jingquan Wang, Lizhen Yi, Linxing Huang, Ziyan Lin, Cai Zhou, Zenghui Yue

    Background and objective: Uric acid and bilirubin are endogenous redox-related metabolites, but their joint association with hemorrhagic transformation (HT) after intravenous thrombolysis (IVT) remains uncertain. We examined whether relatively low uric acid and high total bilirubin define a cumulative biochemical profile associated with hemorrhagic risk. Methods: In this single-center retrospective cohort, we analyzed 733 patients with verifiable pretreatment uric acid and total bilirubin measurements from an IVT registry. Low uric acid (≤278 μmol/L) and high total bilirubin (≥12.67 μmol/L) contributed one point each to a 0–2 adverse-feature score. Any HT was the primary outcome; parenchymal hematoma (PH) and database-defined symptomatic intracranial hemorrhage (sICH) were secondary outcomes. Analyses used logistic regression, Firth bias-reduced regression, multiple imputation and restricted cubic splines. Results: HT occurred in 79/733 patients (10.8%). Observed HT rates were 7.0%, 13.6% and 26.5% across zero, one and two adverse features. Each additional feature was associated with higher odds of HT after covariate adjustment (OR 1.76, 95% CI 1.19–2.60; P = 0.004). PH occurred in 30/733 patients (4.1%), and database-defined sICH occurred in 33/664 patients with observed status (5.0%). Continuous spline analyses in 731 patients showed evidence of an overall association for uric acid ( P overall=0.044) and total bilirubin ( P overall=0.040), without strong evidence of nonlinearity ( P nonlinear=0.193 and P nonlinear=0.704, respectively). No multiplicative interaction between the continuous biomarker terms was detected (OR 0.99, 95% CI 0.77–1.28; P = 0.938). Conclusions: Relatively low uric acid and high total bilirubin defined a cumulative biochemical profile associated with greater odds of HT after IVT. The association requires external validation and should not be interpreted as evidence of causality or as a clinical treatment threshold.

  • Open Access

    Molecular Basis of Glia–ECM Interplay in Central Nervous System Homeostasis and Plasticity

    by Lanlan Wang, Xinyuan Ma, Qinghong Zeng, Mi Liu, Zenghui Yue, Rong Hu

    Interactions between glial cells and the central nervous system (CNS) extracellular matrix (ECM) maintain neural homeostasis and plasticity. In contrast to traditional reviews focusing on biochemistry, this work summarizes the structural and mechanical properties of major ECM subtypes, and illustrates how mechanical and biochemical signals jointly regulate glial activity via key mechanosensitive pathways. Glia in turn dynamically remodel ECM, forming a reciprocal regulatory network. This paper also analyzes characteristic mechanical disorders in Alzheimer’s disease, multiple sclerosis and traumatic brain injury, and addresses targeted therapeutic strategies. Current research challenges and emerging interdisciplinary directions are also discussed. This review provides a valuable reference for exploring neurological disease mechanisms and developing new therapies.

  • Open Access

    LRG1 as a Potential Therapeutic Target in Atherosclerosis: Mechanistic Basis and Current Evidence

    by Jianan Wu, Xia Yi, Lanlan Wang, Kaixuan Yang, Minghuan Liu, Jiawei Song, Zenghui Yue

    Atherosclerosis (AS) is a chronic inflammatory disease of large arteries. It underlies many cardiovascular disorders, including coronary artery disease, myocardial infarction, stroke, and peripheral arterial disease. Current therapies have improved outcomes, especially lipid-lowering, antithrombotic, and anti-inflammatory treatments. Yet residual cardiovascular risk remains, and new molecular targets are still needed. Leucine-rich α-2-glycoprotein 1 (LRG1) is an inflammation-inducible secreted glycoprotein. It has drawn attention because it is linked to pathological angiogenesis, vascular dysfunction, tissue remodeling, and fibrosis. Recent studies indicate that LRG1 is related to AS at several levels. These include circulating clinical associations, plaque localization, and experimental models. In AS, LRG1 may not simply act as a biomarker. It may promote macrophage pro-inflammatory polarization, disturb endothelial homeostasis, support abnormal angiogenesis, and influence extracellular matrix remodeling and plaque structural change. This review examines the biological features of LRG1 and the current evidence connecting it with AS. It also discusses possible mechanisms, therapeutic feasibility, and current limitations. Overall, LRG1 appears to be a promising but still incompletely validated candidate target in AS.

  • Open Access

    Electroacupuncture with different current intensities can improve gastrointestinal motility in diabetic gastroparesis via vagal and sympathetic pathways

    by Yi-Wen Tang, You Zhang, Jin Zhou, Yu-Ting Peng, Yan Zi, Yan-Rong Wei, Zeng-Hui Yue

    Diabetic gastroparesis (DGP) disrupts gastric motility. Electroacupuncture (EA) at Zusanli (ST36) may alleviate DGP symptoms via neural pathways. To investigate how EA current intensities at ST36 regulate neural pathways and improve gastric motility in DGP models. A DGP model was established using intraperitoneal injection of streptozotocin. Gastrointestinal motility was measured in rats after 2 weeks of continuous EA at ST36. Current intensity was selected as 0.5 mA, 1 mA, and 3 mA. Gastric electrodynamics were detected by recording and analyzing the number of gastric discharges. The gastric emptying rate and propulsion rate of the small intestine were measured to assess dynamic gastrointestinal function. Hematoxylin-eosin staining was conducted to measure histopathological changes in the gastric sinus. Reverse transcription-polymerase chain reaction was conducted to determine mRNA levels of Rho guanine nucleotide-binding protein A and Rho-associated coiled-coil forming protein kinase. Western blotting was conducted to determine the expression levels of choline acetyltransferase, tyrosine hydroxylase, Rho guanine nucleotide-binding protein A, and Rho-associated coiled-coil forming protein kinase. Immunofluorescence staining in the stomach was conducted to detect the distribution of C-kit, an interstitial cell of Cajal marker. An enzyme-linked immunosorbent assay was conducted to detect serum levels of acetylcholine and norepinephrine. Treatment with EA improved gastric emptying and gastric smooth muscle disorders in rats with DGP, mitigated pathological damage, and restored the function of interstitial cells of Cajal. In addition, different current intensities of EA affected gastrointestinal function of rats with DGP. The 0.5 mA, 1 mA, and 3 mA EA groups all improved gastrointestinal function. 0.5 mA EA increased acetylcholine levels by increasing protein expression of choline acetyltransferase (P < 0.05), thereby upregulating vagus nerve activity and enhancing parasympathetic nerve regulation. 3 mA EA increased norepinephrine levels (P < 0.05) by increasing protein expression of tyrosine hydroxylase, thereby activating the sympathetic nervous pathway. 1 mA coordinated the function of the vagus and sympathetic nerves to improve gastrointestinal motility. EA with ST36 improved gastric motility in rats with DGP. 0.5 mA EA activated the vagus nerve, while 3 mA EA regulated gastrointestinal motility by activating the sympathetic nerves.


  • Open Access

    Electroacupuncture and Parecoxib Reduce Inflammatory Injury in a Primary Dysmenorrhea Rat Model: Investigating the Role of the COX-2/NF-κB/NLRP3 Pathway

    by Xiao Xue, Shaohua Wang, Juan Li, Hanyu Yuan, Sian Pan, Xin Liu, Zenghui Yue, Yu Liu

    Purpose: Anti-inflammatory drugs relieve primary dysmenorrhea (PDM), and nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) is a potential treatment target. Electroacupuncture (EA) is an effective alternative strategy for treating PDM as it regulates the NLRP3 inflammasome. However, the exact anti-inflammatory mechanism of EA remains unclear. Therefore, this study explored the therapeutic effect of EA on PDM and determined the potential involvement of the cyclooxygenase-2 (COX-2)/nuclear factor κB (NF-κB)/NLRP3 signaling pathway. Patients and Methods: The following pain management interventions were administered to a PDM rat model: saline (control), EA, parecoxib, EA + parecoxib, or ibuprofen. After treatment, the following parameters were examined: torsion behavior; endometrial histopathological morphology and ultrastructure; serum and uterine prostaglandin E2 (PGE2) and prostaglandin F2α (PGF2α) levels; nuclear translocation of NF-κBp65; and the expression of COX-2, phospho-NF-κBp65. NF-κBp65, NLRP3, apoptosis-associated spec-like protein (ASC), pro-cysteine aspartate-specific protease 1 (pro-caspase-1), cysteine aspartate-specific protease 1 (caspase-1), interleukin (IL)-1β, and IL-18. Results: The treatment groups showed considerably reduced pathological uterine injury compared with that of the control. This was associated with decreased PGF2α and increased PGE2 levels. The uterine tissues in the treatment groups showed reduced NF-κBp65 nuclear translocation and a decreasing trend in COX-2, NF-κBp65, phospho-NF-κBp65, NLRP3, ASC, pro-caspase-1, caspase-1, IL-1β, and IL-18 protein expression compared with that of the controls. The levels of each protein in the parecoxib and ibuprofen groups did not differ considerably from those in the EA group. Furthermore, EA markedly improved pain symptoms and pathological damage in PDM rats and downregulated the expression of COX-2/NF-κB/NLRP3 signaling pathway proteins in uterine tissue. Conclusion: Our findings demonstrated superior anti-inflammatory effects of EA + parecoxib on COX-2/NF-κB/NLRP3 signaling pathway-related proteins compared with that of EA alone or single-drug administration.